The global DNA diagnostic market is expected to grow with the CAGR of 9%-12% by 2025

   January 13, 2021
According to a new market report published by Lucintel, the future of the DNA diagnostic market looks promising with opportunities in applications, such as pre-natal DNA carrier screening, pre-implantation diagnosis, newborn genetic screening, infectious disease diagnostics, oncology diagnostics & histopathology, identity diagnostics & forensics, and pharmacogenomics diagnostic testing & drug metabolism/p450 effects. The global DNA diagnostic market is expected to grow with a CAGR of 9%-12% from 2020 to 2025. The major drivers for this market are continuous product modifications, increased preference for efficient diagnostic platforms, and increased research & development activities.

DNA diagnostics is used to identify various diseases, such as cancer, infectious diseases, and myogenic disorders, and to determine the appropriate treatment for the same. In this market, instruments, reagents, and service & software are the major products segments. Lucintel forecasts that instruments will remain the largest product segment over the forecast period due to improved healthcare facilities, availability of user-friendly instruments, their competitive cost structure, reliability, and size.

Within this market, infectious disease diagnostics will remain the largest application segment over the forecast period due to the increasing prevelance of infectious diseases, advantages of DNA testing in infectious diseases for early detection, and technological advancement for diagnostic application.

North America will remain the largest region over the forecast period due to the presence of sophisticated healthcare infrastructure, strong government initiatives, proactive funding for DNA testing research, and high prevalence of chronic diseases in the region.

GE Healthcare, Abbott Laboratories, Agilent Technologies, Beckman Coulter, Bio-Rad Laboratories, Thermo Fisher Scientific, Illumina, Cephide, Hologic, Transgenomic, Siemens Healthcare, Roche Diagnostics, and Qiagen are among the major suppliers in the global DNA diagnostic market.

Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global DNA diagnostic market by product, technology, application, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global DNA Diagnostic Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global DNA diagnostic market by product, technology, application, and region as follows:

By Product [Value ($ Million) shipment analysis for 2014 – 2025]:

  • Instruments

  • Reagents

  • Service & Software

By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:

  • Microarray Based

  • PCR (Polymerase Chain Reaction) Based

  • In-situ Hybridization

  • NGS (Next Generation Sequencing) DNA Diagnosis

By Application [Value ($ Million) shipment analysis for 2014 – 2025]:

  • Pre-Natal DNA Carrier Screening

  • Pre-Implantation Diagnosis

  • Newborn Genetic Screening

  • Infectious Disease Diagnostics

  • Oncology Diagnostics & Histopathology

  • Identity Diagnostics & Forensics

  • Pharmacogenomics Diagnostic Testing & Drug Metabolism/P450 Effects

By Region [Value ($ Million) shipment analysis for 2014 – 2025]:

  • North America

  • United States

  • Canada

  • Mexico

  • Europe

  • United Kingdom

  • Spain

  • Germany

  • France

  • Asia Pacific

  • China

  • India

  • Japan

  • The Rest of the World

  • Brazil


This more than 150 page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at

About Lucintel

Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit

Lucintel Corporate Customers

Market Entry, M & A, Opportunity Screening,...

Private Equity Customers

Buy Side Services (target screening, due diligence, ..)

Customer Quotes

"With more than 20 years experience in the industry, this is the first time we have come across such an extensive market analysis for our industry." Ven Cote, CEO, ZCL

"The insights we gained from Lucintel work helped with our business plan…a wonderful professional job…" Mike Jackson, Stahlin

"The report from Lucintel is useful not only for business planners, but also for the technology officers wanting to create a roadmap …" Dr. Giulio Ranzo, Booz Allen

"The information is so comprehensive, it has allowed us to identify & focus our business development efforts. It saved months of leg-work." Bill Barz, L&L Products

"We bought Lucintel report because it is the best report about our industry…a complete and appropriate analysis." Cesare Andrenacci, Ferretti